Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Track VCRE with free AI briefings, catalyst countdowns, and dilution alerts.

VCRE · Vicore Pharma Holding AB

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

Follow VCRE by email Get an email when VCRE pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about VCRE, unsubscribe in one click. Privacy

📣 What VCRE Says Is Next

mid-2027 · “Reaching full enrollment is the culmination of a coordinated effort by patients, investigators, and clinical teams, and it begins the countdown to topline data expected in mid-2027.”
Company press release, Aug 21, 2026 · SEC filing
mid-2027 · “Reaching full enrollment is the culmination of a coordinated effort by patients, investiga-CEO Comments tors, and clinical teams, and it begins the countdown to topline data expected in mid-2027.”
Company press release, Aug 21, 2026 · SEC filing

Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.

💰 Cash Runway & Dilution Risk

Dilution pressure: 0 · Low

Cash runway not available

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when VCRE files for a raise →

Get the full VCRE picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for VCRE and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z